Remote Dwelling Location Is a Risk Factor for CKD Among Indigenous Canadians.
Oksana Harasemiw, Shannon Milks, Louise Oakley...
https://pubmed.ncbi.nlm.nih.gov/29989009/Actively Recruiting
Led by University of Manitoba · Updated on 2025-06-11
2500
Participants Needed
3
Research Sites
13 weeks
Total Duration
Indigenous people living in rural and remote communities across Manitoba, British Columbia, Alberta, Saskatchewan, and Ontario face higher risks of Chronic Kidney Disease CKD, diabetes, and high blood pressure compared to the general population. This research aims to perform point-of-care testing to identify these conditions early and provide tailored treatment plans. The study seeks to develop a durable CKD surveillance system to reduce the burden of kidney disease and kidney failure in these communities. Participants will receive point-of-care screening conducted by a registered nurse, including demographic and physical data collection, and blood and urine testing. Results are provided during the appointment, and those at high risk of kidney failure are referred to nephrologists, while others receive guidance for primary care follow-up. This approach supports early diagnosis and treatment in both adults and children. Throughout the study, participants will undergo assessments of kidney function biomarkers, diabetes status, blood pressure, and kidney failure risk during the screening visit. The process includes real-time testing and counseling, aiming to ensure ongoing care and monitoring. The total involvement includes one screening day, with follow-up care coordinated based on individual risk levels to help prevent CKD progression and kidney failure.
CONDITIONS
Kidney Check: Diabetes, Blood Pressure & Kidney Health Checks & Care in Indigenous Communities.
M
Maria James, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Manitoba
Lead Sponsor
Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) with point-of-care testing including blood and urine samples, physical measurements, and questionnaire
Duration - Ongoing after screening
Participants who undergo routine care are observed with referrals to specialists or primary care providers based on their risk of kidney failure.
Follow-up visits depend on individual risk and referral recommendations
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Oksana Harasemiw, Shannon Milks, Louise Oakley...
https://pubmed.ncbi.nlm.nih.gov/29989009/Thomas W Ferguson, Navdeep Tangri, Zhi Tan...
https://pubmed.ncbi.nlm.nih.gov/28433383/Paul Komenda, Barry Lavallee, Thomas W Ferguson...
https://pubmed.ncbi.nlm.nih.gov/27257016/Sarah Curtis, Heather Martin, Michelle DiNella...
https://pubmed.ncbi.nlm.nih.gov/33868690/Allison Dart, Barry Lavallee, Caroline Chartrand...
https://pubmed.ncbi.nlm.nih.gov/30374222/Sarah Curtis, AbdulRazaq Sokoro, Heather Martin...
https://pubmed.ncbi.nlm.nih.gov/33615077/Barry Lavallee, Caroline Chartrand, Lorraine McLeod...
https://pubmed.ncbi.nlm.nih.gov/27408755/Paul Komenda, Thomas W Ferguson, Kerry Macdonald...
https://pubmed.ncbi.nlm.nih.gov/24529536/University of Manitoba
Lead Sponsor
Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease
Collaborating Sponsor